Intrinsic Value of S&P & Nasdaq Contact Us

Enzolytics Inc. ENZC OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
13/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ENZC

Enzolytics Inc. (ENZC) has a market capitalization of $1.18M and trades at $0.00. The 52-week range is 0.0002-0.0011.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1, Earnings Per Share (EPS) of $0.00.

The stock has a beta of 0.00, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0002-0.0011
Volume2.83M
Avg Volume (30D)8.57M
Market Cap$1.18M
Beta (1Y)0.00
Company
IPO Date2009-04-08
Employees1
CEOSteven Sharabura
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS2941121079
CUSIP294112107
Income (Latest Year)
Gross Profit$-22.09K
EBITDA$-335K
Operating Income$-357K
Net Income$-394K
EPS$0.00
EPS Diluted$0.00
Shares Outstanding$1.29B
Balance Sheet (Latest Year)
Total Assets$201.68M
Current Assets$200.01M
Cash & ST Investments$200M
Total Liabilities$320.25M
Total Debt$996.34K
Net Debt$996.34K
Total Equity$-118.58M
Debt / Equity-0.01
Valuation Ratios
P/E Ratio-1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message